International Business News - CV http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Central Vermont Public Service Corp. said Wednesday it has set a price of $19 per share for a public offering of nearly 1.2 million newly issued common shares. http://www.ibtimes.com/articles/20081119/central-vermont-utility-prices-stock-offering.htm Wed, 19 Nov 2008 17:37:42 EST CV Therapeutics Inc. winnowed its loss by 26 percent in the third quarter, the biopharmaceutical company said Thursday, because of improved sales of its angina drug Ranexa and greater royalty and collaboration payments. http://www.ibtimes.com/articles/20081106/cv-therapeutics-cuts-loss-on-better-ranexa-sales.htm Thu, 06 Nov 2008 13:29:09 EST The Food and Drug Administration approved Ranexa as a primary treatment for a kind of chest pain, maker CV Therapeutics Inc. said Thursday, adding to its earlier approval of the drug as a secondary treatment. http://www.ibtimes.com/articles/20081106/cv-says-drug-gets-primary-approval-in-angina.htm Thu, 06 Nov 2008 08:47:48 EST A new study says Vermont and its utilities should pursue medium-sized power plants, rather than large ones, as it looks to meet future demand for power. http://www.ibtimes.com/articles/20080820/study-vt-should-rely-on-medium-sized-generators.htm Wed, 20 Aug 2008 18:02:46 EDT Vermont's largest utility and the state Department of Public Service are unveiling a program to introduce new technology in hopes of using electricity more efficiently. http://www.ibtimes.com/articles/20080801/vt-utility-plans-for-smart-power-devices.htm Fri, 01 Aug 2008 16:31:45 EDT Biotechnology company CV Therapeutics Inc. said Monday the Food and Drug Administration will take longer than expected to review a request to approve its drug Ranexa as an initial treatment for angina. http://www.ibtimes.com/articles/20080728/cv-therapeutics-gets-longer-angina-drug-review.htm Mon, 28 Jul 2008 12:31:13 EDT Central Vermont Public Service Corp., which has run an emergency home heating aid program for more than 20 years, said Monday it is starting the program five months early this year in anticipation of a "grave situation" among people overwhelmed by high fuel costs. http://www.ibtimes.com/articles/20080714/vt-utility-kicks-off-heating-aid-program-early.htm Mon, 14 Jul 2008 11:54:19 EDT Biotechnology company CV Therapeutics Inc. said Thursday European regulators approved its chronic angina drug Ranexa, which is called Ranolazine outside the U.S. http://www.ibtimes.com/articles/20080710/cv-therapeutics-gets-european-ok-for-ranexa.htm Thu, 10 Jul 2008 17:03:06 EDT Vermont's 21 electric utilities are joining to urge consumers not to try to beat the high price of oil and other heating fuels by switching to electric heat. http://www.ibtimes.com/articles/20080625/vt-utilities-dont-switch-to-electric-heat.htm Wed, 25 Jun 2008 15:43:38 EDT Biopharmaceutical company CV Therapeutics Inc. said Tuesday it has received a milestone payment of $10 million from TPG-Axon Capital related to the commercial launch of its stress agent Lexiscan. http://www.ibtimes.com/articles/20080624/cv-therapeutics-receives-10m-milestone-payment.htm Tue, 24 Jun 2008 09:47:46 EDT Among the earnings projection stories for Friday, May 9, from AP Financial News: RUTLAND, Vt. (AP) _ Central Vermont Public Service Corp. affirmed its 2008 earnings guidance on Friday, after saying first-quarter earnings rose nearly 4 percent, despite a slight decline in retail revenue. http://www.ibtimes.com/articles/20080509/outlook-roundup-central-vermont-public-service-cogent.htm Fri, 09 May 2008 16:08:34 EDT Central Vermont Public Service Corp. said Friday that first-quarter earnings grew nearly 4 percent as the electric utility's resale revenue offset a slight decline in retail revenue. http://www.ibtimes.com/articles/20080509/central-vermont-public-service-1q-earnings-grow-4-percent.htm Fri, 09 May 2008 13:09:25 EDT